Jim Simons
WVE icon

Jim Simons’s Wave Life Sciences WVE Stock Holding History

Jim Simons’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.33M Buy
597,220
+360,800
+153% +$4.7M 0.01% 1461
2025
Q4 		$4.02M Buy
+236,420
New +$2.4M 0.01% 1431
2025
Q2 		– Sell
-210,220
Closed -$1.7M – 3959
2025
Q1 		$1.7M Buy
210,220
+168,700
+406% +$1.84M ﹤0.01% 2110
2024
Q4 		$514K Sell
41,520
-63,000
-60% -$841K ﹤0.01% 2834
2024
Q3 		$857K Buy
+104,520
New +$625K ﹤0.01% 2540
2024
Q2 		– Sell
-164,620
Closed -$1.02M – 4021
2024
Q1 		$1.02M Buy
164,620
+149,920
+1,020% +$751K ﹤0.01% 2472
2023
Q4 		$74K Sell
14,700
-17,000
-54% -$90.9K ﹤0.01% 3379
2023
Q3 		$182K Sell
31,700
-133,120
-81% -$608K ﹤0.01% 3119
2023
Q2 		$600K Buy
164,820
+133,020
+418% +$537K ﹤0.01% 2764
2023
Q1 		$138K Sell
31,800
-62,700
-66% -$287K ﹤0.01% 3392
2022
Q4 		$662K Sell
94,500
-43,400
-31% -$200K ﹤0.01% 2774
2022
Q3 		$498K Sell
137,900
-25,700
-16% -$85.1K ﹤0.01% 2934
2022
Q2 		$532K Sell
163,600
-41,594
-20% -$80K ﹤0.01% 3132
2022
Q1 		$410K Buy
205,194
+167,894
+450% +$411K ﹤0.01% 3305
2021
Q4 		$117K Buy
+37,300
New +$155K ﹤0.01% 3649
2021
Q3 		– Sell
-87,120
Closed -$580K – 3897
2021
Q2 		$580K Buy
+87,120
New +$569K ﹤0.01% 2907
2021
Q1 		– Sell
-235,620
Closed -$1.85M – 3764
2020
Q4 		$1.85M Buy
+235,620
New +$1.98M ﹤0.01% 2166
2019
Q3 		– Sell
-19,100
Closed -$498K – 3750
2019
Q2 		$498K Buy
19,100
+10,854
+132% +$304K ﹤0.01% 2999
2019
Q1 		$320K Buy
+8,246
New +$335K ﹤0.01% 3070
2017
Q1 		– Sell
-15,400
Closed -$403K – 3435
2016
Q4 		$403K Buy
+15,400
New +$501K ﹤0.01% 2831
2016
Q3 		– Sell
-35,700
Closed -$739K – 3515
2016
Q2 		$739K Buy
+35,700
New +$556K ﹤0.01% 2652

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Jim Simons's WVE Position: Q1 2026 in Review

Jim Simons increased its Wave Life Sciences (WVE) stake by 153% in Q1 2026, buying an estimated $4.7M and bringing the position to 597,220 shares worth $4.33M. The position accounts for 0.01% of the portfolio, ranked #1461.

Jim Simons first reported a position in WVE in Q2 2016 and has held it in 21 quarters since. 231 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Jim Simons held 597,220 shares of Wave Life Sciences worth $4.33M as of Q1 2026.
  • Jim Simons bought 360,800 Wave Life Sciences shares in Q1 2026, an estimated $4.7M.
  • Wave Life Sciences made up 0.01% of Jim Simons's portfolio in Q1 2026, its #1461 holding.
  • Jim Simons first reported a position in Wave Life Sciences in Q2 2016 and has held it in 21 quarters since.
  • 231 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.